News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Company News

Cardinal Health Names Hinrichs, Laws to Senior Financial Positions

DUBLIN, Ohio, May 29, 2007 — Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced the appointment of Jim Hinrichs as executive vice president and controller and Stuart G. Laws as vice president and chief accounting officer.


Hinrichs, 39, will report to Chief Financial Officer (CFO) Jeffrey W. Henderson and will be responsible for financial planning, accounting and external reporting for the $80 billion company.  Laws, 44, will report to Hinrichs and serve as Cardinal Health’s principal accounting officer.


Hinrichs was most recently senior vice president and CFO of Cardinal Health’s Clinical Technologies and Services segment.  He joined the company in February 2004 as vice president of Investor Relations with prior experience as CFO of Sangstat Medical Corp., a publicly traded health-care company, and in various senior financial positions with Merck & Co.


Laws has served as vice president, Accounting and Reporting since joining the company in January.  His prior experience includes serving as CFO of Damon’s International Inc., a restaurant operation and franchising company, and various management positions at the accounting firm of Ernst & Young LLP.


Both appointments are effective on June 29.  Hinrichs and Laws replace Eric Slusser, 47, who has accepted a position as CFO at another public company.


“Eric has been instrumental during his time at Cardinal Health in improving the overall quality of the finance organization,” Henderson said.  “I wish him all the best in his new position.  I am also pleased that our focus on succession planning and talent development has led to the promotion of Jim and Stu to these key leadership positions.  Both are exceptional individuals who have made significant contributions to Cardinal Health.”


About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $80 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.  With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing systems, MedMined® data mining software and the CareFusion™ patient identification system.  The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide.  Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents.  More information about the company may be found at

More Company News

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health


Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...


Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields